Page 20 - Eng Eong News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The Straits Times Practices like mask wearing should suffice as strain is still spread mainly via droplets Singapore has instituted travel restrictions against Britain, forbidding all long-term pass holders and short-term visitors who have been there within the last 14 days from entering or transiting through Singapore. From Monday, the same curbs will apply to travellers from South Africa, where another potentially more contagious strain is circulating. ST PHOTO: LIM YAOHUI https://str.sg/JDZc They can read the article in full after signing up for a free account. Share link: Or share via: Si...

President Xi has pledged to make the country's vaccines a global public good  China's vaccine candidates are being considered by many developing countries  China approved its first Covid-19 vaccine for general public use, developed by state-owned drug maker Sinopharm.   The pharmaceutical giant announced on Thursday that the vaccine, which is said to be 79 per cent effective, had been approved. ADVERTISEMENT The efficacy rate is based on interim analysis of Phase III clinical trials of the drug, developed by the Beijing Biological Products Institute, a unit of Sinopharm subsidiary China ...

China approves its first Covid vaccine – developed by state-owned drug company State-owned drug maker Sinopharm announced the breakthrough on Thursday with the vaccine said to be 79% effective, based on interim analysis of Phase III clinical trials . China has approved a Covid-19 vaccine by Sinopharm (Image: REUTERS) The Daily Star's FREE newsletter is spectacular! Sign up today for the best stories straight to your inboxInvalid EmailSomething went wrong, please try again later. Sign up today! When you subscribe we will use the information you provide to send you these newsletters. Somet...

Investors obviously considered these to be underwhelming, however.

SHARE The company making a Covid-19 vaccine with China’s state-owned manufacturer Sinopharm, said on Wednesday that its shot is 79.34 per cent effective and they are seeking to get approval to start distributing the first coronavirus drug in China. The vaccine is already being used in several countries as global Phase 3 trials continue. As different trials progress, fragmentary efficiency data have been released, but this is the first indication from the company behind the drug. The efficacy rate, based on an interim analysis of Phase 3 clinical trials, is lower than the 86 per cent rate f...